SCIENTIFIC INDUSTRIES INC
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: March 29, 2024 | SCIENTIFIC INDUSTRIES, INC. |
|---|---|
| (Registrant) | |
| /s/Helena R. Santos | |
| Helena R. Santos | |
| President, Chief Executive Officer, and Treasurer | |
| Date: March 29, 2024 | SCIENTIFIC INDUSTRIES, INC. |
| (Registrant) | |
| /s/Reginald Averilla | |
| Reginald Averilla Chief Financial Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| Helena R. Santos | President, Chief Executive Officer, and Treasurer | March 29, 2024 |
| Reginald Averilla | Chief Financial Officer | March 29, 2024 |
| John A. Moore | Chairman of the Board | March 29, 2024 |
| Christopher Cox | Director | March 29, 2024 |
| Marcus Frampton | Director | March 29, 2024 |
| Jurgen Schumacher | Director | March 29, 2024 |
| John Nicols | Director | March 29, 2024 |
CONTENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB firm ID 339) | F-2 |
|---|---|
| Report of independent registered public accounting firm (PCAOB firm ID 324) | F-3 |
| Report of independent registered public accounting firm (PCAOB firm ID 103) | F-4 |
| Consolidated financial statements: | |
| Consolidated Balance Sheets as of December 31, 2023 and 2022, and June 30, 2022 | F-6 |
| Consolidated Statements of Operations and Comprehensive Loss for the Year Ended December 31, 2023, for the Six Months Ended December 31, 2022 and for the Year Ended June 30, 2022 | F-7 |
| Consolidated Statements of Changes in Stockholders’ Equity for the Year Ended December 31, 2023, for the Six Months Ended December 31, 2022 and for the Year Ended June 30, 2022 | F-8 |
| Consolidated Statements of Cash Flows for the Year Ended December 31, 2023, for the Six Months Ended December 31, 2022 and for the Year Ended June 30, 2022 | F-9 |
| Notes to financial statements | F-10 – F-36 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.